A critical safety concern is avoiding duplicate paracetamol exposure when using multiple products
Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study
This paradox, too much sugar in the blood but not enough in the cells, is one of the primary drivers of the fatigue that accompanies metabolic syndrome and type 2 diabetes
Current Pharmaceutical Design, 24(18), 1972-1989
In other words, micro-dosing of weight loss drugs is off-label (not approved by the FDA), unproven, and not supported by clinical trial data
Have a history of cardiovascular disease and could benefit from a reduced risk of major cardiovascular events